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Abstract
Obsessive-compulsive disorder (OCD) is an anxiety-spectrum disorder characterized by persistent
intrusive thoughts (obsessions) and repetitive actions (compulsions). Dysfunction of cortico-striato-
thalamo-cortical circuitry is implicated in OCD, though the underlying pathogenic mechanisms are
unknown. SAP90/PSD95-associated protein 3 (SAPAP3) is a postsynaptic scaffolding protein at
excitatory synapses that is highly expressed in the striatum. Here we show that mice with genetic
deletion of SAPAP3 exhibit increased anxiety and compulsive grooming behavior leading to facial
hair loss and skin lesions; both behaviors are alleviated by a selective serotonin reuptake inhibitor.
Electrophysiological, structural, and biochemical studies of SAPAP3 mutant mice reveal defects in
cortico-striatal synapses. Furthermore, lentiviral-mediated selective expression of SAPAP3 in the
striatum rescues the synaptic and behavioral defects of SAPAP3 mutant mice. These findings
demonstrate a critical role for SAPAP3 at cortico-striatal synapses and emphasize the importance of
cortico-striatal circuitry in OCD-like behaviors.
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OCD, a common and incapacitating psychiatric disorder, affects ∼2 percent of the world
population1,2. OCD is characterized by persistent intrusive thoughts (obsessions), repetitive
actions (compulsions) and excessive anxiety. Clinical expression of OCD is heterogeneous in
the types of obsessions and compulsions, heritability, and co-morbid conditions, likely
reflecting heterogeneity in the underlying pathology3. In addition, there are many disorders
that share features with OCD, termed “OC-spectrum disorders” that include Tourette’s
syndrome, trichotillomania, and body dysmorphic disorder.
The neurobiological basis of OCD is unclear. However, lesions, functional neuro-imaging, and
neuropsychological studies have indicated that the cortico-striato-thalamo-cortical (CSTC)
circuitry may play a key role in the pathogenesis of OCD3-5. Familial studies of OCD indicate
that the risk to first degree relatives is 3-12 times greater than the general population, similar
to familial risk rates observed for bipolar disorder and schizophrenia6-8. In addition,
concordance for OCD is greater among pairs of monozygotic (80-87%) than dizygotic twins
(47-50%)9,10. However, no genetic factors have yet been identified as a cause of OCD,
presumably reflecting etiological heterogeneity within the disorder. While many of the
symptoms of OCD can be ameliorated by enhancing serotonin neurotransmission, it is not clear
at the cellular level whether defects in the serotonergic system are the primary cause3-5. Indeed,
dopaminergic and glutamatergic neurotransmitter systems have also been implicated5,11. Here
we show that targeted deletion of SAPAP3 in mice leads to a behavioral phenotype similar to
OCD: compulsive over-grooming behavior, increased anxiety, and response to selective
serotonin reuptake inhibitors (SSRIs). In these mutant mice, we have identified defects at
cortico-striatal synapses, part of the circuitry implicated in OCD, and we show that selective
expression of SAPAP3 in the striatum rescues the synaptic and behavioral defects. These
findings suggest that defects in excitatory transmission at cortico-striatal synapses may underlie
some aspects of OCD.
SAPAP3 mutant mice exhibit self-inflicted facial lesions
SAPAP family proteins were originally identified as postsynaptic density (PSD) components
that interact with the PSD95 and Shank families of proteins12-13, two other multi-domain
postsynaptic scaffolding proteins at excitatory synapses. Together, these three groups of
proteins are thought to form a key scaffolding complex that regulates the trafficking and
targeting of neurotransmitter receptors and signaling molecules to the postsynaptic membrane
of excitatory synapses14-16. There are four highly homologous genes in the SAPAP
family13. Of these, SAPAP1, 3, and 4 are highly, but differentially, expressed in several regions
of the brain17,18. Notably, SAPAP3 is the only member highly expressed in the striatum. To
facilitate study of the in vivo function of SAPAP proteins at synapses, we generated knockout
mice for the SAPAP3 gene using homologous recombination in mouse ES cells
(Supplementary Fig. S1a-d). Mice homozygous for SAPAP3 deletion (SAPAP3-/-) were born
at the expected Mendelian rate, grew to adulthood with body weights similar to wildtype mice,
and were fertile. Anatomical and histological analyses of brain showed that SAPAP3-/- mice
were grossly normal (data not shown).
By the age of 4-6 months, however, SAPAP3-/- mice developed lesions on their head, neck,
and snout regions (Fig. 1a). This phenotype was 100% penetrant. Lesions were usually first
noticed as a patch of hairless skin under the eyes or swelling of the snout, progressing to
relatively symmetric bilateral lesions encompassing large parts of the neck and head.
SAPAP3-/- mice developed lesions regardless of whether they were housed alone or with
cagemates. Lesions were not observed on wildtype or heterozygous mice even when housed
in the same cage with SAPAP3-/- mice from birth, thereby excluding the possibility that lesions
were caused by allogrooming or were the result of aggressive encounters with other
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SAPAP3-/- mice. In fact, SAPAP3-/- mice were not observed to behave aggressively, but were
often seen engaged in self-grooming whether they were housed alone or in groups.
Given the obvious lesions on the SAPAP3-/- mice, we tested the possibility that their lesions
might be caused by peripheral cutaneous defects, such as inflammation or abnormal afferent
sensation. We examined facial skin from pre-lesion SAPAP3-/- mice that exhibited increased
grooming. Histological analysis of skin did not reveal any anatomical differences among
wildtype, SAPAP3+/- and SAPAP3-/- mice, and no lymphocytic or granulocytic infiltration
was observed (Supplementary Fig. S1e, f). We did, however, find lymphocytic/granulocytic
infiltration in skin with lesions, likely due to injury and infection (Supplementary Fig. S1g).
No differences were detected in sensory innervation among wildtype, SAPAP3+/- and
SAPAP3-/- mice; hair-nerve end organs, lobular corpuscle-like nerve endings, and free
epidermal nerve endings were present and not different between SAPAP3-/- and control mice
(Supplementary Fig. S1h, i). Thus, our examination revealed no obvious peripheral defects
that would suggest a cause for the lesions. Together, these findings raised the possibility that
SAPAP3-/- mice have excessive and injurious self-grooming behavior.
OCD-like behaviors of SAPAP3 mutant mice
To determine whether SAPAP3-/- mice groom excessively, we continuously videotaped
habituated, individually-housed mice for 24 hours. Isolated SAPAP3-/- mice showed
dramatically increased grooming bouts and spent significantly more time self-grooming than
wildtype littermates (Fig. 1b, c). The increased grooming was present throughout the day,
including the period when mice usually sleep (1000 - 1400h). Both mutant mice with facial
lesions and mice yet to develop lesions showed similar degrees of increased grooming (Fig.
1d), indicating that the lesion itself was not the cause of increased grooming. We thus conclude
that SAPAP3-/- mice have excessive and injurious levels of self-grooming, a phenotype
reminiscent of compulsive behaviors.
Because the SAPAP3-/- mice exhibited a compulsive-like behavior, we considered whether
their phenotypes further resemble OC-spectrum disorders. We therefore examined other OCD-
like behaviors that are measurable in mice: increased anxiety and response to typical
pharmacological agents. To test whether SAPAP3-/- mice exhibit increased anxiety, we
conducted open field, dark-light emergence, and elevated zero maze tests. In the open field,
mice with anxiety-like phenotypes tend to stay along the walls, avoiding the center zone.
SAPAP3-/- mice spent much less time exploring the center area than wildtype littermates (Fig.
1e). However, activities along the walls and corners, areas believed to be less stressful, were
not different between wildtype and SAPAP3-/- mice (Fig. 1f). In the dark-light emergence test,
the latency to cross from a dark into a brightly lit chamber (a stressful environment), and the
time spent in the brightly lit chamber were examined. SAPAP3-/- mice took longer to cross
from the dark to the lit chamber and spent less time in the lit chamber than wildtype controls
(Fig. 1g, h), though total activity in the chambers was similar between wildtype and
SAPAP3-/- mice (Fig. 1i). Finally, in the elevated zero maze test, we found that SAPAP3-/-
mice took longer to cross into the open areas (riskier environment) and spent significantly less
time exploring the open areas compared to wildtype controls (Fig. 1j, k), whereas total activity
was not different between the two genotypes (Fig. 1l). Together, these results indicate that
SAPAP3-/- mice have an anxiety-like phenotype.
We next evaluated whether drugs used to treat OCD would be effective in reducing the
abnormal behavior in SAPAP3-/- mice. SSRIs are a first-line treatment for OCD; although their
mechanism of action is not well understood, these drugs alleviate symptoms in approximately
50% of OCD patients3. Fluoxetine treatment for 6 days (once per day at 5mg/kg, i.p.) did not
affect grooming behavior of wildtype mice. However, this treatment significantly reduced the
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excessive grooming in SAPAP3-/- mice (Fig. 2a). Furthermore, fluoxetine dramatically
reduced anxiety-like behaviors in SAPAP3-/- mice in the dark-light emergence test without
affecting their total activity (Fig. 2b, c). In contrast, a single injection of fluoxetine (5mg/kg,
i.p.) had no effects on their excessive grooming behavior (Fig. 2d). Thus, SAPAP3-/- mice
exhibit compulsive-like grooming and increased anxiety, both of which are alleviated by 6
days of fluoxetine treatment.
Altered cortico-striatal synaptic transmission in SAPAP3-/- mice
The observations that SAPAP3 is the only member of the SAPAP family highly expressed in
the striatum (Fig. 3a) and that SAPAP3-/- mice show OCD-like behaviors suggest that there
may be defects in striatal neurotransmission in SAPAP3-/- mice. Since SAPAPs are
postsynaptic proteins of excitatory synapses12,17 that directly bind PSD95 family proteins,
which are known to regulate the trafficking of both AMPA- and NMDA-type glutamate
receptors (AMPAR and NMDAR, respectively)19-21, we focused on cortico-striatal synapses,
which constitute the large majority of glutamatergic synapses in the striatum. We performed
extracellular recordings from acute striatal brain slices. A field recording electrode was placed
in the dorso-lateral striatum and a stimulating electrode was placed nearby in the corpus
callosum. Recordings were obtained in the presence of picrotoxin, a GABAA receptor
antagonist, to block contaminating responses from intra-striatal GABAergic circuitry. We
found that field excitatory postsynaptic potentials (fEPSP) were significantly reduced in
SAPAP3-/- mice compared to wildtype littermates (Fig. 3b). Axonal excitability and
presynaptic function were not different from wildtype, as indicated by the slope of the input-
output curves normalized to the peak response, the relationship of stimulation intensity to the
amplitude of the action potential component (NP1; Supplementary Fig. S2a, b), and paired-
pulse ratios (Fig. 3c), suggesting that the reduction in total field responses was likely due to a
postsynaptic impairment in synaptic transmission.
We next evaluated NMDAR-mediated responses by recording in the presence of an AMPAR
antagonist (NBQX) and the NMDAR co-factor glycine, in the absence of magnesium.
Surprisingly, in contrast to the reduction we observed in the total fEPSP amplitude, which is
dominated by AMPAR transmission under these conditions, the NMDAR-dependent fEPSPs
were elevated in SAPAP3-/- mice (Fig. 3d, e). These findings indicate a differential effect of
SAPAP3 deletion on extracellular field potentials dependent upon AMPAR and NMDAR
activity. We further tested whether the synaptic defects are unique to the striatum, by examining
synaptic transmission in the hippocampus, in which SAPAP1, 3 and 4 are highly
expresed17,18. We found no defects in CA3-CA1 hippocampal basal synaptic transmission in
SAPAP3-/- mice (Supplementary Fig. S2c, d), likely reflecting functional redundancy or
compensation by other members of the SAPAP family. Together these findings identify an
important role for SAPAP3 in postsynaptic glutamatergic synaptic function at cortico-striatal
synapses.
Altered NMDAR composition of the PSD in striatum
To investigate the potential role of SAPAP3 in postsynaptic assembly, we examined the levels
of a select group of PSD proteins that directly or indirectly interact with SAPAPs using
biochemically-purified PSD fractions from the striatum of wildtype and SAPAP3-/- mice. We
found no significant differences in the levels of PSD95, PSD93, or Shank proteins in the striatal
PSD between the genotypes (Fig. 4a, b). However, the level of NR1, the obligatory subunit of
the NMDAR, was significantly increased (Fig. 4a, b). This result is consistent with our data
from extracellular recordings in the striatum, which showed increased NMDAR field potential
responses. While we cannot exclude the possibility that the larger NMDAR-dependent fEPSPs
include a contribution from activated conductances other than NMDARs (a limitation of
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extracellular recordings), our electrophysiological data in combination with these biochemical
findings suggest that an increase in NMDARs in the PSD may result in increased synaptic
NMDAR activity in SAPAP3-/- mice. Interestingly, we also found that the level of NR2B, the
“juvenile” subunit of the NMDAR, was significantly increased in the PSD of SAPAP3-/- mice,
whereas NR2A, the “adult” subunit, was significantly reduced (Fig. 4a, b). In contrast, we
found no significant changes in the overall levels of NR1, NR2A and NR2B subunits in the
total striatal lysate (Supplementary Fig. S3a, b), suggesting that the changes in these subunits
occur exclusively at the PSD. Synaptic NMDARs are known to undergo a developmental
switch from predominantly NR1/NR2B to NR1/NR2A or NR1/NR2A/NR2B during the first
two postnatal weeks of life22-27. Although the underlying molecular mechanisms of this
developmental switch are not well understood, postsynaptic scaffolding proteins, including the
PSD95 and SAPAP family of proteins, have been implicated in this process28-31. Our data
indicate that the NMDAR subunit composition at cortico-striatal synapses of adult
SAPAP3-/- mice is similar to that of wildtype juvenile mice27,28, suggesting that SAPAP3
may play an important role in synaptic NMDAR subunit switching and maturation at cortico-
striatal synapses.
Structure of cortico-striatal synapses in SAPAP3 mutant mice
To determine whether these electrophysiological and biochemical defects are accompanied by
morphological changes, we examined the spine density of medium spiny neurons (MSNs) in
the striatum using both Golgi staining and DiI filling by Diolistics. We found similar spine
densities on MSNs in SAPAP3-/- and wildtype mice at P21 (Supplementary Fig. S3c-e) and in
adults (data not shown), indicating that spine formation and maintenance were not affected by
the lack of SAPAP3 proteins.
We next examined whether deletion of SAPAP3 affects PSD ultrastructure at cortico-striatal
synapses using electron microscopic (EM) analysis to measure the length and thickness of the
PSD in the striatum (Fig. 4c, d). We found no significant difference in length of the PSD
between SAPAP3-/- and wildtype mice (Fig. 4e). The PSD is reported to exhibit a laminar
organization: NMDARs, scaffolding proteins, and signaling proteins reside in the electron-
dense layer near the synaptic membrane, while proteins linked to trafficking and the actin
cytoskeleton reside in the filamentous fringe towards the cytoplasm32. Accordingly, we
independently measured the thickness of the “dense layer” and the fringe “light layer”. We
found a small but significant reduction in thickness of the dense layer but not the light layer
(Fig. 4f, g) of the PSD in striatal synapses in SAPAP3-/- mice, suggesting a subtle defect in the
structure of the postsynaptic complex. This finding is consistent with the proposed role of
SAPAP3 as a postsynaptic scaffolding protein at excitatory synapses12,17.
Lentiviral-mediated expression of SAPAP3 in the striatum rescues behavioral
and synaptic defects of mutant mice
Our findings of altered cortico-striatal synaptic function and structure in SAPAP3 mutant mice,
along with pre-existing evidence for the role of striatal circuitry in the pathogenesis of OC-
spectrum disorders led us to ask whether loss of SAPAP3 in the striatum was critical for the
phenotypes of SAPAP3-/- mice. We therefore investigated whether selective expression of
SAPAP3 in the striatum was sufficient to rescue the phenotypes of SAPAP3-/- mice. We
generated lentiviral vectors that express either green fluorescent protein (GFP) alone or a GFP-
SAPAP3 fusion protein. GFP was fused to SAPAP3 at the amino-terminus, a region with no
known protein-protein interaction sites or motifs. As expected, GFP-SAPAP3 fusion proteins
properly localized to synapses when transfected into cultured neurons (Supplementary Fig.
S4a).
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Lentiviruses expressing either GFP or GFP-SAPAP3 were delivered to the striatum of
SAPAP3-/- mice by bilateral microinjections at postnatal day 7. To minimize injury and
maximize lentiviral infection, we gave injections at one anterior and one posterior site per
hemisphere and delivered lentivirus to 8 locations per hemisphere by injection of lentivirus
along the needle path (Fig. 5a; see Methods). Sustained expression of GFP and GFP-SAPAP3
was observed in both dorsal and ventral striatum in post-mortem examination of brains at the
end of the study (Fig. 5b-e’; Supplementary Fig. S4b, c).
At 4-6 months after injection, behavioral analyses were conducted to assess grooming, facial
lesions, and anxiety-like behaviors. When examined by continuous videotaping, excessive
grooming was markedly reduced in SAPAP3-/- mice injected with GFP-SAPAP3 lentivirus in
comparison to SAPAP3-/- mice injected with the control GFP lentivirus (Fig. 5f). Moreover,
facial lesion severity was also significantly reduced in SAPAP3-/- mice injected with GFP-
SAPAP3 lentivirus (Fig. 5g, h). All 8 SAPAP3-/- mice injected with the control GFP lentivirus
developed open skin lesions (6 with large, 1 with medium, and 1 with small open wounds). In
contrast, only 3 of the 8 SAPAP3-/- mice injected with GFP-SAPAP3 lentivirus developed
open skin lesions (1 with large, 1 with medium, and 1 with small open wounds), while 2 had
small hairless patches and 3 had normal skin conditions (Fig. 5i). Furthermore, SAPAP3-/-
mice injected with GFP-SAPAP3 lentivirus also showed reduced anxiety-like behavior in the
dark-light emergence test (Fig. 5j, k) with no change in total activity (data not shown). Finally,
lentiviral-mediated expression of GFP-SAPAP3 in the striatum also rescued defects in cortico-
striatal synaptic transmission in SAPAP3-/- mice (Fig. 5l, m). Together, these data show that
early postnatal expression of GFP-SAPAP3 selectively in the striatum is sufficient to alleviate
the major manifestations of the OCD-like phenotype in SAPAP3-/- mice.
Discussion
Although dysfunction of cortico-striato-thalamo-cortical circuitry has been widely implicated
in OC-spectrum disorders, the nature of this dysfunction remains unclear. Our study of
SAPAP3 mutant mice has identified an important role for SAPAP3 at cortico-striatal synapses
and, although there are inherent limitations of evaluating thought content in mice, our study
further suggests that cortico-striatal synaptic defects may be central to the genesis of OCD-
like behaviors. These conclusions are supported by several lines of evidence. First,
SAPAP3-/- mice exhibit OCD-like behaviors: excessive time spent on performing a ritualistic
action to the point of being self-injurious, increased anxiety-like behaviors, and response of
these manifestations to SSRIs. Second, SAPAP3 is expressed at excitatory, but not inhibitory,
synapses15. Third, SAPAP3 is the only member of the SAPAP3 family that is highly expressed
in the striatum. Fourth, SAPAP3 mutant mice have reduced cortico-striatal synaptic
transmission and an NMDAR subunit composition suggestive of immature cortico-striatal
synapses. Finally, selective expression of SAPAP3 in the striatum of SAPAP3-/- mice rescues
the synaptic defects and OCD-like behaviors.
Anxiety is attributed primarily to dysfunction of the amygdala and ventral hippocampus.
Interestingly, SAPAP3, unlike SAPAP1 and SAPAP4, is not highly expressed in the amygdala
(Supplementary Fig. S5a-d), while all 4 members of the SAPAP family are expressed in the
ventral hippocampus (Supplementary Fig. S5e-h), suggesting that anxiety-like behavior in
SAPAP3-/- mice is unlikely to be due to the lack of SAPAP3 in amygdala or ventral
hippocampus. The unique expression of SAPAP3 in the striatum and the alleviation of the
anxiety-like behavior by lentiviral-mediated expression of GFP-SAPAP3 in the striatum
suggest that the anxiety-like behavior in SAPAP3-/- mice originate from striatal defects.
Because the amygdala projects to the striatum, it is also possible that some functions of
amygdalar-striatal projections are impaired in SAPAP3-/- mice. Additionally, our video
surveillance data indicate that SAPAP3 mutant mice have disrupted sleep pattern
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(Supplementary Fig. S6), which is alleviated by fluoxetine treatment (Supplementary Fig. S7).
This sleep disturbance may also contribute to the anxiety-like behavior in SAPAP3-/- mice.
A principal role of the striatum is to integrate the various inputs arriving from the cortex and
use this information to select certain motor and/or cognitive programs (decision making),
which are subsequently carried out through the direct and indirect pathways of the basal
ganglia4. A prominent model for OCD is that an activity imbalance between the direct and
indirect pathways leads to behavioral abnormalities of OCD3, and recent studies have shown
that the two pathways are differentially regulated at cortico-striatal synapses33-35. We have
identified defects in both AMPAR- and NMDAR-dependent synaptic transmission at cortico-
striatal synapses. These data are from extracellular field recordings, representing a population
average of the effects on individual neurons. If the observed effects are differentially
manifested by MSNs in the direct or indirect pathway, an imbalance in activity could be readily
envisioned.
Studies of the mechanisms of OC-spectrum disorders have mostly focused on the serotonergic
and dopaminergic systems. However, recent genetic association studies of OCD in humans
have implicated genes important for glutamatergic neurotransmission36-38. Together with our
study of SAPAP3 in mice, these observations raise the possibility that defects in excitatory
synaptic transmission in the cortico-striatal circuit may contribute to the pathogenesis of OC-
spectrum disorders in humans.
METHODS SUMMARY
Behavioral analysis
SAPAP3 knockout mice were generated by homologous recombination in R1 embryonic stem
cells using standard procedures39. Adult mice age 4-8 months were used for behavioral
analyses. For analyses of grooming behaviors40, habituated, individually housed animals were
video-taped for 24 hours under 700 lux (day) and ∼2 lux (red light at night) illumination. Tests
for anxiety-like behaviors were performed as described41, 42. All experiments were done blind
to genotypes. Because of the presence of obvious facial lesions in SAPAP3 mutant mice, it is
impossible to perform video decoding in a blind manner. To avoid bias, trained individuals
unfamiliar with the project (listed in the Acknowledgements) were recruited to decode the
videos.
Cortico-striatal electrophysiology
300 μm acute sagittal brain slices from P17-P25 mice were used for all experiments. The field
recording electrode was placed in the dorso-lateral striatum and a monopolar stimulation
electrode was placed in the corpus callosum. All recordings were performed at 30-32°C and
in the presence of picrotoxin and all data were collected and analyzed prior to unblinding of
genotypes.
Stereotaxic injection
One week old SAPAP3-/- mice were anesthetized and placed in a mouse head holder. GFP
lentivirus or GFP-SAPAP3 lentivirus was bilaterally injected into the striatum through 2 sites
at 8 locations per hemisphere. Behavioral analyses were performed 4-6 months after injection.
METHODS
Mice
SAPAP3 knockout mice were generated by homologous recombination in R1 embryonic stem
cells using standard procedures. A targeting vector was designed to replace exon 3 (containing
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the translation initiation codon) of the SAPAP3 gene with a NEO cassette. Genotypes were
determined by PCR of mouse tail DNA, using primer F1
(ATTGGTAGGCAATACCAACAGG) and R1 (GCAAAGGCTCTTCATATTGTTGG) for
the wildtype allele (147 base pairs), and F1 and R2 (CTTTGTGGTTCTAAGTACTGTGG; in
neo cassette) for the mutant allele (222 base pairs). Primer locations are indicated in Fig. S1.
Grooming behavior40
Adult mice age 4-8 months were used. Habituated, individually housed animals were video-
taped for 24 hours under 700 lux (day) and ∼2 lux (red light at night) illumination. As behaviors
were most representative at 0200-0600, 1000-1400, and 1800-2200 hr, these segments were
selected for analyses using Noldus Observer software (Leesburg, VA). The total amount of
time in each 4-hour segment spent grooming, eating, sleeping, rearing, digging or pushing
bedding (shifting) was determined, along with general states of activity. Grooming included
all sequences of face-wiping, scratching/rubbing of head and ears, and full-body grooming.
Bouts of behavior lasted at least 3 seconds; pauses longer than 3 seconds constituted a new
bout. Observer reliability was determined with Cohen’s kappa43.
Anxiety-like behaviors41, 42
Zero maze—An elevated zero maze41 was indirectly illuminated at 60 lux. Testing
commenced with an animal being introduced into a closed area of the maze. Behavior was
video-taped for 5 min and subsequently scored by trained observers using the Noldus Observer
(Nodus Information Technology). Anxiety-like behavior was deduced based upon the percent
time spent in the open areas and the latency to enter the open areas. Total activity time in the
maze was an indicator of motor activity. Observer reliability was determined with Cohen’s
Kappa.
Open field—Spontaneous locomotor activity was evaluated over 30 min in an automated
Omnitech Digiscan apparatus (AccuScan Instruments, Columbus, OH) as described44.
Locomotor activity was assessed as total distance traveled (cm). Anxiety-like behavior was
defined by the percent time spent in the center as contrasted to percent time spent in the
perimeter (thigmotaxis) of the open field.
Dark-Light Emergence Test45—Mice were adapted in an adjacent room to low light
conditions (∼40 lux) and the test room was initially under similar illumination. Testing was
conducted in a two-chambered test apparatus (Med-Associates, St. Albans, VT), with one side
draped in black cloth (e.g., dark-chamber) and the other illuminated at ∼1400 lux (e.g., light-
chamber) with a 170 mA high intensity house light and overhead fluorescent lamps.
Immediately upon placing the mice into the darkened chamber, the lighted chamber was
illuminated and the door between the two chambers was opened. The mice were allowed to
freely explore the apparatus for 5 min. The latency to emerge from the darkened into the lighted
chamber and the percent time spent in the illuminated chamber were used as indices of anxiety-
like behaviors. Total motor activity in the two chambers was measured by infrared beam-
breaks.
Fluoxetine treatment
Adult mice 4-6 months of age were injected with fluoxetine (5 mg/kg, i.p.) once a day for one
or six days and behaviors were tested 24 hours after the final injection. Grooming and anxiety-
like behaviors were tested as described above.
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Hematoxylin and eosin staining was performed on facial skin below the eyes following a
standard protocol. For visualization of sensory nerves in skin, SAPAP3 mutant mice were
crossed with Thy1GFP-J mice46. Mice were perfused transcardially with saline and 4%
paraformaldehyde and skin from just below the eyes was dissected and post-fixed for 24 hours.
Confocal images were taken from 50 μm cryosections. Skin lesions were scored as follows:
0=normal skin; 1=hairless patches; 2=small open-wound lesions, length < 2mm; 3=moderate
open-wound lesions, length 2-4mm; 4=large open-wound lesions, length >4mm.
Cortico-striatal electrophysiology
300 μm acute sagittal brain slices from P17-P25 mice were used for all experiments. Recording
perfusion solution contained (in mM): 119 NaCl, 2.5 KCl, 1.2 NaH2PO4, 26 NaHCO3, 1
MgCl2, 2 CaCl2, and 0.1 picrotoxin (GABAA receptor antagonist). Slicing and recovery
solutions were identical to perfusion solution except for containing 0.5 CaCl2 and no
picrotoxin. APV (50 μM) and NBQX (50 μM) were obtained from Tocris (Ellisville, MO).
Solutions were continuously equilibrated with 95% O2 and 5% CO2 (pH 7.4) and perfusion
flow rate was 2 ml/min. Slices were allowed to recover for a minimum of 1 hr at 30-32°C
following slicing. All recordings were performed at 30-32°C.
The field recording electrode was placed in the dorso-lateral striatum and a monopolar
stimulation electrode was placed in the corpus callosum. Current was delivered to the
stimulating electrode using an A.M.P.I. Stimulus Isolator (A.M.P.I., Israel) for 150 μsec. Three
distinct components were resolved in the majority of recordings: stimulation artifact, negative
peak 1 (NP1, action potential-derived based on latency, resistance to NBQX and picrotoxin,
and sensitivity to tetrodotoxin) and negative peak 2 (NP2, fEPSP based on latency and
sensitivity to NBQX; in addition, sensitivity to tetrodotoxin indicates response not due to direct
activation by stimulating electrode current). The callosal stimulation site was chosen over an
intra-striatal site to minimize activation of non-cortical axons. Data were acquired at 20 kHz
and filtered at 2 kHz using MultiClamp 700B amplifier and pClamp 10.0 software (Axon
Instruments, Sunnyvale, CA). Data were analyzed offline using Clampfit 10.0 (Axon
Instruments). Five consecutive responses were averaged prior to measuring amplitude, slope
or area in the respective assays. When amplitudes are reported, similar conclusions were
obtained by slope analysis. Paired-pulse responses were evoked using a stimulation intensity
that yielded the maximal fEPSP response. Slope values used for paired-pulse ratios refer to
slope during the period from 20-80% of the peak response. NMDAR fEPSPs were evoked
using the same stimulation intensity that yielded the maximal fEPSP response under the basal
recording conditions used to generate the input-output curves. The area of NMDAR field
potential responses was measured during a standard 20 millisecond time window beginning
approximately 8 milliseconds after stimulation. All data were collected and analyzed prior to
unblinding of genotypes. In addition, NMDAR field potential recordings and correlative PSD
biochemical studies were performed in two different labs and were unblinded at the same time.
For in vivo viral expression rescue experiments, the same slicing, recording, and analysis
methods were used as described above except that the stimulating and recording electrodes
were placed within the fluorescent green tissue. Only slices where green cells were visible in
the dorsolateral recording region were used. Viral rescue experiments were performed and
analyzed blinded to the viral identity.
Diolistics
“Bullets” were prepared by coating tungsten particles (Bio-rad) with DiI (Molecular Probes-
Invitrogen) dissolved in methylene chloride as described47. Mice were perfused transcardially,
first with normal saline, and then with buffered 4% paraformaldehyde. Fixed mice were
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decapitated and the head was allowed to post-fix for 24-48 hours in buffered 4%
paraformaldehyde at 4°C. Brains were dissected and 250 μm coronal slices were cut on a
vibratome.
Diolistic filling of individual cells was performed using a standard Bio-Rad biolistic system.
Slices were placed into the interior chamber of a Falcon organ tissue culture dish (catalog
number 3037) and excess buffer was removed. A Millipore 3.0 μm Isopore filter (catalog
number TSTP04704) was placed to rest on top of the tissue culture dish and a Kimwipe was
placed on top of the Millipore filter. Bullets were shot through the Kimwipe and filter barrier
using a helium charge of 80psi. Individual labeling of 3-15 striatal medium spiny neurons was
successful in approximately 50% of slices. Following the diolistic procedure, slices were
allowed to incubate in buffer at 4°C for 1-2 hours. Following incubation, slices were
immediately mounted and imaged on a confocal microscope.
Lentivirus production and stereotaxic injection
Lentivirus vector was based on FUGW48 and modified by replacing the ubiquitin promoter
with a CMV promoter to improve neuronal expression. GFP was fused to the amino-terminus
of SAPAP3 to generate the GFP-SAPAP3 construct. The cDNA clone encoding GFP or GFP-
SAPAP3 was placed downstream of the CMV promoter between BamHI and EcoRI sites48.
Viral particles were produced by transient transfection of 293T cells with the GFP or GFP-
SAPAP3 lentiviral vector along with the envelope (VSVg) and packaging (Δ8.9) vectors. High
titer viral suspensions were obtained by ultra-centrifugation at 77,000 X g for 90 min.
One week old SAPAP3-/- mice were anesthetized with a mixture of ketamine and xylazine
(i.p), and placed in a mouse head holder (David Kopf Instruments, Tujunga, CA). GFP
lentivirus or GFP-SAPAP3 lentivirus was bilaterally injected into the striatum through 2 sites
at 8 locations per hemisphere. At each of the injection sites, the microinjection needle was
advanced to the deepest (ventral) position for the first injection; additional injections were
made every 0.3 mm while withdrawing the injection needle. The coordinates from Bregma
were: injection site 1, location 1-3: anterior 0.5 mm, mediolateral 1.4 mm, dorsoventral 2.8,
2.5, 2.2 mm; injection site 2, location 4-8: anterior 0.2 mm, mediolateral 1.7 mm, dorsoventral
3.3, 3.0, 2.7, 2.4, 2.1 mm. For each injection location, 90 nl of virus was injected using Nanoject
II (Drummond Scientific, Broomall, CA), and the needle was left in place for 3 min after each
injection.
EM analysis
Striatal tissues for EM analysis were processed and quantitatively analyzed according to
protocols previously described32. Synapses with clear membranes (likely to be cut orthogonal
to the plane of the synaptic membrane) were photographed at 15,000X magnification. Data
collection and analysis were performed by observers blinded to genotypes. For every clearly-
defined synapse, data for PSD length and PSD thickness were collected.
PSD preparation and Western blot
PSD fractions of the striatum were prepared as described17,49, separated on SDS-PAGE and
probed with specific antibodies. The relative amount of β-tubulin and β-actin were used as
loading controls for quantification. Antibodies for SAPAP3, PSD95, PSD93, Shank and NR2B
have been described previously17,49,50. Antibodies for NR1 (mouse monoclonal) and NR2A
(rabbit polyclonal) were from BD Biosciences (San Jose, CA) and Upstate (Charlottesville,
VA), respectively.
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Figure 1. Facial lesions, excessive grooming and anxiety-like behaviors in SAPAP3 mutant mice
a, SAPAP3-/- mice have facial and neck skin lesions (arrows). b, c, SAPAP3-/- mice (KO)
showed more grooming bouts (b) and spent more time in self-grooming (c) than wildtype mice
(WT) at all times examined. d, Pre-lesion and post-lesion groups of SAPAP3-/- mice showed
similar degrees of increased grooming. e,f, In the open field test, SAPAP3-/- mice spent less
time in the center (e), whereas locomotion along the perimeter was comparable to wildtype
controls (f). g-i, In the dark-light emergence test, SAPAP3-/- mice took longer to cross from
the dark to the brightly lit chamber (g) and spent less time in the brightly lit chamber (h), while
total activity in both chambers was similar (i). j-l, In the elevated zero maze, SAPAP3-/- mice
took longer to cross into the open areas (j) and spent less time in these areas than wildtype
controls (k), while total activity in both open and closed areas was similar (l). *p < 0.05, **p
< 0.01, ***p < 0.001, repeated measures ANOVA for b-e and two-tailed t-test for f-l; all data
are presented as means ± SEM from 8-9 mice per genotype, Cohen’s kappa for intra-observer
agreement exceeded 0.92.
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Figure 2. Fluoxetine treatment alleviates excessive grooming and anxiety-like behavior
a, Daily fluoxetine treatment (5 mg/kg, i.p.) over 6 days reduced grooming behavior in
SAPAP3-/- mice. b, c, Given over 6 days, fluoxetine alleviated anxiety-like behavior of
SAPAP3-/- mice in the dark-light emergence test. d, A single injection of fluoxetine (5 mg/kg,
i.p.) had no effect on the grooming behavior of SAPAP3-/- mice. **p < 0.01, ***p < 0.001,
repeated measures ANOVA; all data are presented as means ± SEM from 9-11 mice per group,
Cohen’s kappa for intra-observer agreement exceeded 0.92.
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Figure 3. Altered cortico-striatal synaptic transmission in SAPAP3 mutant mice
a, Only SAPAP3 mRNA is highly expressed in the striatum (STR). b, Cortico-striatal field
potential recordings of acute brain slices show decreased fEPSPs in SAPAP3-/- mice. p< 0.001,
repeated measures ANOVA. Inset shows a typical field recording (black trace) and sensitivity
to NBQX (red trace). NP1, negative peak 1. c, Paired-pulse ratios (slope fEPSP#2/slope
fEPSP#1) are similar between wildtype and SAPAP3-/- mice. d, Example traces of NMDAR-
dependent fEPSPs recorded in the presence of 50 μM NBQX, 0 mM Mg2+ and 2 mM glycine.
Sensitivity to APV indicated by red trace. e, NMDAR fEPSP area is increased in SAPAP3-/-
mice. *p < 0.05, two-tailed t-test; number of recordings in parentheses.
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Figure 4. Structural and biochemical analyses of cortico-striatal synapses in SAPAP3 mutant mice
a, b, The levels of PSD95, PSD93 and Shank in striatal PSD fractions are not affected in
SAPAP3-/- mice. The levels of NR1 and NR2B subunits are increased, whereas that of NR2A
is decreased. β-actin and β-tubulin were used as loading controls. *p < 0.05, two-tailed t test.
c, d, Electron micrographs show the presence of synaptic vesicles (arrowheads), postsynaptic
densities (arrows) and dendritic spines (stars). e, The length of the PSD is not significantly
different in wildtype and SAPAP3-/- mice. f, g, The thickness of the dense layer (f) of the PSD
in SAPAP3-/- mice, but not the light layer (g), is reduced. p< 0.001, two-tailed t test; n=94 for
wildtype and n=92 for SAPAP3-/- mice.
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Figure 5. Lentiviral-mediated rescue of behavioral and synaptic defects in SAPAP3 mutant mice
a, Diagram showing the approximate locations of microinjections in the striatum of
SAPAP3-/- mice. Injection site 1, locations 1-3 are more anterior than injection site 2, locations
4-8. b-c’, Brain sections from a SAPAP3-/- mouse injected with GFP lentivirus show GFP
fluorescence (b, c) and an absence of SAPAP3 staining (b’, c’). d-e’, Brain sections from a
SAPAP3-/- mouse injected with GFP-SAPAP3 lentivirus show both GFP fluorescence (d, e)
and SAPAP3 immunostaining (d’, e’). f, Compared to SAPAP3-/- mice injected with GFP
lentivirus, SAPAP3-/- mice injected with GFP-SAPAP3 lentivirus showed significantly
reduced over-grooming behavior. **p < 0.01, two-tailed t-test; n=8 mice/group for f, i-k. g-
h, SAPAP3-/- mice injected with GFP-SAPAP3 lentivirus (h) had reduced severity of facial
lesions when compared to SAPAP3-/- mice injected with GFP lentivirus (g). i, Semi-
quantitative lesion scores. **p < 0.01, Mann-Whitney U test. j-k, Reduced anxiety-like
behaviors in SAPAP3-/- mice injected with GFP-SAPAP3 lentivirus in the dark-light
emergence test, including decreased latency to cross from the dark to light chamber (j) and
increased time in the light chamber (k). *p < 0.05, two-tailed t-test. l, m, Field recordings from
infected striatal area of P21-P25 SAPAP3-/- mice injected with GFP-SAPAP3 lentivirus
showed an increase in cortico-striatal fEPSP amplitude (l) and a reduction of NMDAR-
dependent fEPSP area (m). p < 0.001, repeated measures ANOVA for l; *p < 0.05, two-tailed
t-test for m; n is 12 and 10 for l, and 10 and 9 for m for GFP injected and GFP-SAPAP3 injected,
respectively .
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